Trans-Pacific Partnership Agreement threatens public health

An editorial to be published by the scientific journal Addiction has been made available online, revealing that negotiations are underway behind closed doors for a far-reaching new trade and investment agreement that could tie the hands of governments' future alcohol and tobacco control policies in perpetuity.

According to editorial author Jane Kelsey, Professor of Law at the University of Auckland, the nine-country Trans-Pacific (TPPA) currently being negotiated between Australia, Brunei, Chile, Malaysia, New Zealand, Peru, Singapore, United States and Vietnam, with Canada, Japan and Mexico in the wings, aims to set a 'gold standard' for removing barriers to the global alcohol and tobacco industries and give them greater leverage over domestic . The goal is to produce a state-of-the-art agreement that other states in the Asia Pacific Economic Cooperation (APEC) grouping will adopt, culminating in a Free Trade Area of the Asia Pacific.

The draft TPPA text is secret, aside from chapters and background documents that have been leaked. Despite the secrecy, Kelsey says it is clear that the cumulative effect of its substantive rules and procedural requirements would shift the balance of policy-making power firmly in favour of transnational corporate interests. By ensuring that domestic alcohol and tobacco policy and regulation pose minimal impediments to global strategies, and that industry has a role in writing them, the draft TPPA threatens progressive policies. At its core, the TPPA threatens sovereignty and democratic governance. The problem is with the agreement itself.

TPPA negotiations are not going forward unopposed. The American Medical Association has already called for the exclusion of measures affecting the supply, distribution, sale, advertising, promotion or investment in and from trade agreements. Tobacco control advocates are well advanced in their campaign, bringing pressure at the national level and at the stakeholder programmes held on the margins of the formal TPPA negotiating rounds.

In Australia, The Public Health Association of Australia (PHAA) is working with other health, medical and fair trade organisations to lobby the Australian government to ensure that it refuses investor-state dispute settlement provisions applying to Australia and that it insists that public health and access to medicines are not compromised in the developing country parties to the agreement. The PHAA has also organised discussions between public health experts and Australia's trade negotiators, written to politicians, issued press releases, and organised several public events to raise awareness in the public health community about the risks to health associated with the TPPA, including during the negotiations in Melbourne.

But Kelsey asserts that there is danger in focusing on issue silos. Beyond alcohol and tobacco are other public health concerns, such as Pharmaceutical Benefits Schemes, and beyond public health is a multitude of other negative impacts, from mining and sustainable livelihoods to indigenous rights and culture. These trade agreements represent a major public health challenge which requires action from people interested in reducing the harm from addiction and substance use around the world.

add to favorites email to friend print save as pdf

Related Stories

The alcohol industry needs more scrutiny

Jun 01, 2011

The influence of "Big Alcohol" in the health arena deserves as much scrutiny as Big Pharma and Big Tobacco, especially in light of evidence of bias in funded research, unsupported claims of benefit, and inappropriate promotion ...

WHO chief accuses 'big tobacco' of dirty tricks

Oct 10, 2011

The World Health Organization's chief on Monday urged governments to unite against "big tobacco", as she accused the industry of dirty tricks, bullying and immorality in its quest to keep people smoking.

Last orders for warning-free booze in Australia

Jul 12, 2011

Australia's major alcohol brands on Tuesday launched voluntary health warnings on their labels targeting children, pregnant women and excessive boozing in a country famed for its binge-drinking culture.

Lighting up the powerful global smoking lobby

Jan 17, 2008

Global public health efforts to reduce smoking are at odds with the interests of the tobacco industry. According to a case study published in the online open access journal Globalization and Health, competing tobacco compan ...

Recommended for you

Recognize and treat Internet addiction

Jun 18, 2013

(Medical Xpress)—Do you stay up late into the night using the Internet? Are you grumpy or anxious when you cannot log on? Do you feel the need to use the Internet more and more to feel satisfied? Do you stay online longer ...

Missing enzyme linked to drug addiction

Jun 17, 2013

A missing brain enzyme increases concentrations of a protein related to pain-killer addiction, according to an animal study. The results will be presented Monday at The Endocrine Society's 95th Annual Meeting in San Francisco.

Australia cracks down on synthetic drugs

Jun 16, 2013

Australia imposed an interim ban on 19 synthetic cannabis and cocaine-like drugs on Sunday as part of a crackdown on the psychoactive substances which mimic the highs of their illegal counterparts.

User comments

More news stories

Laughing gas does not increase heart attacks

(Medical Xpress)—Nitrous oxide—best known as laughing gas—is one of the world's oldest and most widely used anesthetics. Despite its popularity, however, experts have questioned its impact on the risk ...

Model recreates wear and tear of osteoarthritis

(Medical Xpress)—There's a reason osteoarthritis is often called wear-and-tear arthritis: Repeated stress on joints over time results in degeneration of the soft cartilage that normally distributes loads ...

New technologies for retinal therapies

The future of the investigation and treatment of retinal disorders is already here at the MedUni Vienna: in the new Christian Doppler "OPTIMA" (Ophthalmic Image Analysis) laboratory headed by Ursula Schmidt-Erfurth, ...

Protalix signs supply deal with Brazilian govt

Shares of Protalix BioTherapeutics Inc. jumped in premarket trading Wednesday after the drug developer announced a deal that requires the Brazilian government to buy at least $280 million of the company's Gaucher disease ...